MedPath

Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24

Completed
Conditions
Unsafe Sex
IV Drug Usage
Registration Number
NCT03637322
Lead Sponsor
Phoenix Children's Hospital
Brief Summary

This study will evaluate the implementation of a PrEP program for youth aged 13-24 in Phoenix, AZ. Numbers of youth who initiate PrEP, how long they continue with PrEP, and the barriers for youth who are trying to initiate and continue taking PrEP will be examined.

Detailed Description

This observational study will describe the barriers encountered and the benefits found as youth engage in a PrEP program, the Phoenix PrEP Access Project and as they participate in PrEP provided through standard medical care. This study does not investigate the safety, efficacy or other medical benefits of PrEP, but looks at the issues surrounding youth who are trying to access PrEP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PrEP Uptake3 years

Uptake of PrEP offered to youth presenting for PrEP ages 13-24

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Phoenix Children's Hospital, Bill Holt Clinic

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath